SEC 13F Intelligence

Managers / Q2 2019 · view latest →

MORGENS WATERFALL VINTIADIS & CO INC

CIK 0001016150 · 1270 AVENUE OF THE AMERICAS, SUITE 214, NEW YORK, NY, 10020 · 2122184100

Reported Value
$145M
Q2 2019
Positions
55
Filings on Record
29
2019–present window
Filed
Aug 14, 2019
original filing

Summary

Morgens Waterfall Vintiadis & Co Inc reported $145M in U.S.-listed holdings across 55 positions for Q2 2019.

Its largest position, MSFT, represents 5.6% of the portfolio.

Compared with Q1 2019, the fund opened 11 new positions and exited 12.

Portfolio Metrics

Turnover
+23.3%
vs prior filed quarter
Top-10 Concentration
+41.0%
share of reported value
Largest Position
+5.6%
Microsoft
New / Exited
11 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $140MQ1 ’19Q2 ’19: $145MQ3 ’19: $130MQ4 ’19: $147MQ1 ’20: $107MQ1 ’20Q2 ’20: $156MQ3 ’20: $175MQ4 ’20: $185MQ1 ’21: $180MQ1 ’21Q2 ’21: $196MQ3 ’21: $194MQ4 ’21: $186MQ1 ’22: $159MQ1 ’22Q2 ’22: $106MQ3 ’22: $91MQ4 ’22: $115MQ1 ’23: $122MQ1 ’23Q2 ’23: $141MQ3 ’23: $124MQ4 ’23: $135MQ1 ’24: $145MQ1 ’24Q2 ’24: $131MQ3 ’24: $129MQ4 ’24: $131MQ1 ’25: $88MQ1 ’25Q2 ’25: $136MQ3 ’25: $146MQ4 ’25: $137MQ1 ’26: $81MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 93.4%Other: 5.0%ADR: 1.3%REIT: 0.4%
  • Common Stock · 93.4% · $136M
  • Other · 5.0% · $7M
  • ADR · 1.3% · $2M
  • REIT · 0.4% · $529,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MCDMCDONALDS CORPNEW+22.9K22.9K+$5M$5M
SNPSSYNOPSYS INCNEW+30.0K30.0K+$4M$4M
METAFACEBOOK INCNEW+18.8K18.8K+$4M$4M
WORKSLACK TECHNOLOGIES INCNEW+90.5K90.5K+$3M$3M
ELDORADO RESORTS INCNEW+70.0K70.0K+$3M$3M
TMUST MOBILE US INCNEW+31.0K31.0K+$2M$2M
MDTMEDTRONIC PLCNEW+15.0K15.0K+$1M$1M
CHRSCOHERUS BIOSCIENCES INCNEW+50.0K50.0K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

54 positions
#IssuerClass% PortfolioValueShares
1MSFTMICROSOFT CORPhistory →COM5.55%$8M60.2K
2LULULULULEMON ATHLETICA INChistory →COM5.38%$8M43.3K
3NFLXNETFLIX INChistory →COM4.34%$6M17.1K
4OKTAOKTA INChistory →CL A3.96%$6M46.6K
5TTDTHE TRADE DESK INChistory →COM CL A3.87%$6M24.7K
6CAESARS ENTMT CORPCOM3.83%$6M470.0K
7ATLASSIAN CORP PLCCL A3.74%$5M41.5K
8AMZNAMAZON COM INChistory →COM3.59%$5M2.8K
9NEW RELIC INCCOM3.43%$5M57.5K
10TWLOTWILIO INChistory →CL A3.32%$5M35.4K
11MCDMCDONALDS CORPhistory →COM3.27%$5M22.9K
12NVDANVIDIA CORPhistory →COM3.14%$5M27.8K
13ASMLASML HOLDING N Vhistory →N Y REGISTRY SHS2.75%$4M19.2K
14ZYNGA INCCL A2.74%$4M650.0K
15AMATAPPLIED MATLS INChistory →COM2.71%$4M87.5K
16SNPSSYNOPSYS INChistory →COM2.66%$4M30.0K
17WMTWALMART INChistory →COM2.63%$4M34.5K
18METAFACEBOOK INChistory →CL A2.50%$4M18.8K
19DPZDOMINOS PIZZA INChistory →COM2.49%$4M13.0K
20BABOEING COhistory →COM2.38%$3M9.5K
21WORKSLACK TECHNOLOGIES INChistory →COM CL A2.34%$3M90.5K
22BBYBEST BUY INChistory →COM2.31%$3M48.0K
23REATA PHARMACEUTICALS INCCL A2.23%$3M34.4K
24BYDBOYD GAMING CORPhistory →COM2.23%$3M120.0K
25ELDORADO RESORTS INCCOM2.22%$3M70.0K
26HDHOME DEPOT INChistory →COM1.79%$3M12.5K
27EHTHEHEALTH INChistory →COM1.78%$3M30.0K
28TMUST MOBILE US INChistory →COM1.58%$2M31.0K
29ADMAADMA BIOLOGICS INChistory →COM1.47%$2M550.0K
30ILMNILLUMINA INChistory →COM1.27%$2M5.0K
31VVISA INChistory →COM CL A1.20%$2M10.0K
32MAMASTERCARD INChistory →CL A1.18%$2M6.5K
33MDTMEDTRONIC PLChistory →SHS1.01%$1M15.0K
34UNHUNITEDHEALTH GROUP INCCOM0.91%$1M5.4K
35CHRSCOHERUS BIOSCIENCES INCCOM0.76%$1M50.0K
36INCYINCYTE CORPCOM0.70%$1M12.0K
37TABULA RASA HEALTHCARE INCCOM0.69%$999,00020.0K
38LABORATORY CORP AMER HLDGSCOM NEW0.67%$968,0005.6K
39WRIGHT MED GROUP N VORD SHS0.55%$805,00027.0K
40HRTXHERON THERAPEUTICS INCCOM0.50%$725,00039.0K
41AZNNASTRAZENECA PLCSPONSORED ADR0.37%$533,00012.9K
42MGPMGM GROWTH PPTYS LLCCL A COM0.36%$529,00017.3K
43BPBP PLCSPONSORED ADR0.36%$523,00012.5K
44MRKMERCK & CO INCCOM0.36%$523,0006.2K
45ROYAL DUTCH SHELL PLCSPON ADR B0.35%$512,0007.8K
46JPMJPMORGAN CHASE & COCOM0.35%$511,0004.6K
47CRSPCRISPR THERAPEUTICS AGNAMEN AKT0.32%$471,00010.0K
48NKENIKE INCCL B0.31%$445,0005.3K
49EDITEDITAS MEDICINE INCCOM NEW0.26%$371,00015.0K
50GMGENERAL MTRS COCOM0.23%$338,0008.8K
51PFEPFIZER INCCOM0.22%$314,0007.3K
52RCKTROCKET PHARMACEUTICALS INCCOM0.21%$300,00020.0K
53THERAPEUTICSMD INCCOM0.20%$291,000112.0K
54CLLSCELLECTIS S ASPONSORED ADS0.18%$265,00017.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$81M14May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$137M23Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$146M22Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$136M21Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$88M17May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$131M22Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$129M24Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$131M23Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$145M36May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$135M34Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$124M27Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$141M34Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$122M31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$115M39Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$91M31Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$106M28Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$159M26May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$186M27Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$194M30Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$196M31Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$180M34May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$185M29Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$175M29Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$156M31Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$107M30May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$147M50Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$130M51Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$145M55Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$140M56May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.